Serological tests using anti-TPM3 and anti-TMOD3 antibodies demonstrated higher sensitivity, specificity, and accuracy in diagnosing early stages of endometriosis (stages I and II) compared to the commonly used marker CA125. This evidence concerns the gene TMOD3 and endometriosis.